March 28, 202: Gulf Capital, a leading growth markets alternative investment firm, announced today its two-year growth plans for ART Fertility Clinics, the fastest growing provider of fertility treatment services in the Gulf Cooperation Council (GCC) states. With increased awareness coupled with the technological advancements in the field, the fertility sector in India is forecasted to continue to grow at 12%+ CAGR annually over the next five years. The new chapter of ART Fertility Clinics will see the implementation of an ambitious two-year rollout of 18 IVF clinics across India. The first two clinics in Gurgaon and New Delhi have commenced medical operations. They are to be followed by clinics in Ahmedabad and Hyderabad (April), Mumbai and Chennai (May), Bangalore and Kolkata (July). The rest of the rollout will be announced in Sept 2021.
Launched in early 2015 in collaboration with IVI RMA Global, ART Fertility clinics is now an independent and leading provider of fertility treatments with the highest success rates internationally (67% Pregnancy rate: 1.3 Embryos per transfer, no donor eggs or sperm). ART Fertility Clinics has established itself as a global thought leader in healthcare science and innovation, having deployed the most advanced infrastructure and technologies in its clinics. Some of these technologies and equipment are being introduced in India for the very first time. ART fertility clinics has its own state-of-the-art genetic lab that utilises the latest NGS system. Having achieved over 5500 + pregnancies in less than five years, ART Fertility Clinics’ success is driven by the scientific and personalised approach of highly skilled physicians, embryologists and support medical team. With a focus on original research and publications, ART Fertility Clinics has become an international referral center for patients seeking advanced treatments especially after multiple failed cycles using their own eggs.
ART Fertility Clinics has assembled a very experienced management team to oversee this ambitious rollout across multiple international geographies whilst continuing to deliver the best-in-class treatment and success rates.
Dr Karim El Solh, Chief Executive Officer of Gulf Capital, said: “We are thrilled to back the strongest management and medical team within the IVF sector for its ambitious expansion in India. ART Fertility Clinics is the fastest growing IVF service provider in the GCC, and we are excited to be collaborating with ART Fertility’s management to take this platform to the next level. Our investment in ART Fertility Clinics is Gulf Capital’s largest equity investment to date and includes the first corporate carve-out in our Firm’s history (Gulf Capital invested over US$ 100 million to acquire a controlling stake in ART Fertility Clinics in Jan 2020). The rapid expansion of Art Fertility Clinics across Asia cements Gulf Capital’s long track record of building global leaders out of the GCC.”
Dr (Professor) Human Fatemi, Group Medical Director for ART Fertility Clinics, remarked: “Reproductive Medicine is a relatively young field, however over the past few years, the uptake of assisted reproduction medicine to conceive has increased exponentially worldwide, especially amongst the urban population. Infertility has been on the rise due to the ever-evolving lifestyle patterns and other disorders. However, most of the treatment protocols are based upon western treatment plans. While the IVF market in India is growing rapidly, there is a clear need to address issues like standardised clinical protocols based upon ethnicity, genetic makeup, structured training, and ethical practices. At ART Fertility Clinics, we are undertaking fundamental research across all related areas including genetics, based upon our observations and trials locally. It has been our constant endeavor to assist more and more couples to fulfill their dream of starting a family by providing the most advanced fertility treatments in accordance with international guidelines, coupled with the right technology. Our partnership with Gulf Capital helps us offer our services to an even broader segment of the population.”
Mr. Suresh Soni, Global CEO of ART Fertility, added: “We are excited to launch the most advanced IVF clinics in India as we embark on our next phase of expansion and growth. We share a common vision: ‘Cogito, Ergo Sum….I think, therefore I am … The cornerstone of our success is good science and technology, which translates into the best medical outcomes for our patients. We have world-renowned IVF specialists and embryologists working in state-of-the-art facilities. We shall continue to deliver the best treatments and services to our patients so that they receive the best value for their money.”
Mr. Vinesh Gadhia, CEO, ART Fertility Clinics, India concluded: “We were very impressed by what Suresh Soni and Dr. Human Fatemi have been able to accomplish in such a short period of time. ART Fertility Clinics’ research-focused and patient-centric approach has allowed it to build an impressive track record that compares extremely favorably with the best IVF centers globally. With the India market expected to continue to expand at double-digit growth rates over the next five years, we are confident that ART Fertility Clinics will expand its coverage and services into new territories within Tier one and Tier two cities in India to deliver world leading pregnancy and live birth rates. We are enthusiastic about our future together and look forward to working closely with the team on this new phase of growth.”
News Source: https://www.gulfcapital.com/
Disclaimer: The content of the above information is sourced (or provided), in entirety or in parts from an external source and the content may or may not be edited. The Wealth Today shall not be held liable for damages arising out of any action taken with respect to the use or consumption of information or service published above or anywhere else on the website. This website does not guarantee the accuracy, views, opinions or any promises expressed in the above news.
If you find any errors or discrepancies in the above information, you can write to us at email@example.com.